Structural imaging remains an essential component of diagnosis, staging and response
assessment in patients with cancer; however, as clinicians increasingly seek to …

Since its first suggestion as possible option for liver radioembolization treatment, the
therapeutic isotope holmium-166 (166Ho) caught the experts' attention due to its imaging …

Well-differentiated neuroendocrine tumors (NETs) are globally increasing in prevalence and
the liver is the most common site of metastasis. Neuroendocrine liver metastases (NELM) …

Radioembolization is a treatment option for colorectal cancer (CRC) patients with
inoperable, chemorefractory hepatic metastases. Personalized treatment requires …

Purpose Peptide receptor radionuclide therapy (PRRT) using [177Lu] Lu-DOTATATE has
been shown to effectively prolong progression free survival in grade 1–2 …

In neuroendocrine neoplasms (NENs), the presence of distant metastases has a severe
impact on survival leading to a relevant decrease in the 5-y survival rate. Here, 90Y …

Hepatocellular carcinoma is the fifth most common cancer and second leading cause of
cancer-related death globally. More than half of all patients are in China. For nearly 10 …

Secondary cancers of the liver are more than twenty times more common than primary
tumors and are incurable in most cases. While surgical resection and systemic …

The process of transcatheter arterial chemoembolization is characterized by the ability to
accurately deliver chemotherapy drugs with minimal systemic side effects and has become …

The liver is a common site of metastases from many cancers, particularly those originating in
the gastrointestinal tract. Liver transplantation is an uncommonly used but promising and at …